Spotlight on Spironolactone Oral Suspension for the Treatment of Heart Failure: Focus on Patient Selection and Perspectives

Vascular Health and Risk Management
doi 10.2147/vhrm.s210150
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

Profile of Sacubitril/Valsartan in the Treatment of Heart Failure: Patient Selection and Perspectives

Vascular Health and Risk Management
2017English

Spotlight on Telotristat Ethyl for the Treatment of Carcinoid Syndrome Diarrhea: Patient Selection and Reported Outcomes

Cancer Management and Research
Oncology
2019English

Mechanical Circulatory Support for Advanced Heart Failure : Effect of Patient Selection on Outcome

Circulation
Cardiovascular MedicinePhysiologyCardiology
2001English

Spironolactone for Heart Failure With Preserved Ejection Fraction

New England Journal of Medicine
Medicine
2014English

Clinical Effects of Combined Treatment by Optimal Dose of Furosemide and Spironolactone on Diastolic Heart Failure in Elderly Patients

Experimental and Therapeutic Medicine
MedicineCancer ResearchImmunologyMicrobiology
2015English

Abatacept for the Treatment of Adults With Psoriatic Arthritis: Patient Selection and Perspectives

Psoriasis: Targets and Therapy
DermatologyRheumatology
2018English

Chemical Peels in the Treatment of Acne: Patient Selection and Perspectives

Clinical, Cosmetic and Investigational Dermatology
Dermatology
2018English

In Focus: Spotlight on the September 14 Issue

Neurology
Neurology
2010English

Effects of Mineralocorticoid Receptor Antagonist Spironolactone on Atrial Conduction and Remodeling in Patients With Heart Failure

Journal of Cardiology
Cardiovascular MedicineCardiology
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy